Are These Marijuana Stocks On Your Radar 

Big-name marijuana stocks remain some of the most intriguing companies in the market. Despite the fact that the small and mid-cap pot stocks present a unique opportunity, most tend to focus on the larger companies in the cannabis industry. These large companies have worked to gain the spots at the top of the pot stock market, and for good reason. With large production capacities and even larger plans, these companies remain some of the most prominent amongst the market.

Of course, we have to consider the fact that the largest companies usually see the highest levels of volatility. But, volatility is characteristic of marijuana stocks overall. Volatility, however, can be positive for some as it allows for the potential of short term, big gains. Additionally, it also means that there is a heightened amount of potential for big losses. All of this considered, the most important factor to acknowledge is one’s own individual investment strategy. With this in mind, investing in pot stocks can be made much easier.

[Read More]Marijuana Stocks To Watch: The Effect Of A Down Trend

North American Marijuana Stocks To Watch This Month

As well Due to mostly legal reform at the state level, 2019 legal marijuana sales are projected to produce over $10 billion in revenue. Products ranging from flower, oils, and tinctures which are being used to help alleviate chronic pain, cancer, terminal illness, and some stress-related mental disorders. Recreational use is becoming legal in a growing number of states. With all of this 2020 is looking like a promising year for marijuana stocks.

Marijuana Stocks To Watch: Another MSO

Liberty Health Sciences (LHSIF Stock Report) (LHS) is considered to be one of the more prominent multi-state operators in the industry. The company has seen as much growth during the past month or so. In that time, it was able to produce as much as $5 million in gross profit. This number represents an almost 400% gain from the same time last year.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks To Watch: The Effect Of A Down Trend

Within the course of the past year or so, we have witnessed marijuana stocks overcome more issues. This is the effect of the high levels of volatility that have swept through the cannabis industry. Some of this is due to the shift in legislation as well as uncertainty regarding the future of marijuana stocks. While uncertainty is warranted, it seems as though fear is not. Many analysts believe pot stocks will grow substantially over the next few years.

Currently, we are witnessing the plight of speculative trading take its grasp. With high fluctuations, some pot stocks may be worth watching, while some are undoubtedly on a  downward path. Some of the largest flops in the market have come from the biggest companies. This just goes to show that downtrends do not discriminate based on size, but rather on perceived value. The reality is until the market can calm down in volatility, things will continue to move around. All we can do is search for the value in the market and invest wisely.

Marijuana Stock To Watch: A Cannabis Extraction Company

MediPharm Labs (MEDIF Stock Report) is a cannabis company that provides extractions and extraction services in the cannabis industry. One of the key aspects that separates them from the rest, is that the company is working in a growing market.

Extractions have become one of the main ways to utilize cannabis for many consumers around the world. With legalization currently in select areas, this looks like it could be just the beginning. MediPharm Labs is positioned to take advantage of this niche market, but only time will tell. With some big contracts in the works, the company remains a pot stock to watch.

Continue reading
 0 Comments
0 Comments

2 Marijuana Stocks To Watch Before Next Week

Marijuana stocks have had a wild ride over the past year or so. In that time, we have seen some big changes affect both the present and the future of the cannabis industry. These large shifts in both the public perception of cannabis and legal measures presiding over the industry, all result in the market we have today.

With so much changing so quickly, there’s no doubt that the cannabis industry will be one to watch. With a great amount of information at hand, finding info about a given pot stock can be accomplished in an easier way. Though finding that value can be a challenge, several marijuana stocks continue to present themselves as players for future growth.

Marijuana Stocks To Watch: Mergers And Acquisitions

4Front Ventures (FFNTF Stock Report) (FFNT) is one of the more promising cannabis companies operating in the industry. The company states that it is working toward long term success as its production capabilities have continuously been tested throughout time. The company also has a committed leadership structure which it utilizes to fulfill its goals. Additionally, the company has stated that it’s hands-on expertise and unique growth opportunities have all added to it being one of the more prominent marijuana stocks to watch.

The company recently announced that after closing a merger with Cannex, it has moved forward with testing its new subsidiaries, operational capacities. With this merger, the two should be able to increase production and manufacturing to new levels. Leo Gontmakher, COO of 4Front stated that “to say I am proud of my team is an understatement. Taking advantage of our pre-merger planning work, we formally took over 4Front’s production and processing operations in August. By late September, we had introduced Marmas and Pebbles, two of our most successful edibles brands, to the Massachusetts medical cannabis market.”

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 13, 2019

Will These Marijuana Stocks Be Ready For 2020?

With many marijuana stocks looking to rebound from the current downtrend, only a few have managed to bounce back. Some of these marijuana stocks to watch may not be the largest, but they present an interesting opportunity for the sector. One of the main reasons for the downtrend comes in the form of high volatility. This is mostly due to the effect of speculative trading.

Click Here To Read More

2 Marijuana Stocks To Watch Before Friday 13th

Though some might believe marijuana stocks haven’t reached a bottom yet. There are others who believe that the cannabis industry is set for big growth in 2020. With so much news being thrown around the industry, how can we decide on which marijuana stocks to buy? This question, of course, has a multi-part answer that involves a thorough amount of research.

See For Yourself

Pot Stocks To Watch Before 2020: Aphria Inc. (APHA)

Aphria Inc (APHA Stock Report) has been a struggling marijuana stock in recent times to earn strong returns for investors. In the last two years, its stock has dipped over 25%. Although there have been some bright moments they have, nonetheless, been short-lived. But could recent developments pose a stronger year next year for Aphria?

Continue Reading

The post Marijuana Stocks Newsletter – December 13, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

The Green Organic Dutchman Holdings Ltd. (TGOD) (TGOD.TO) Announces a $41.7 Million Senior Secured Credit Facility

The Green Organic Dutchman Announces a $41.7 Million Senior Secured Credit Facility

The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that the Company has entered into a binding term sheet with Maynbridge Capital Inc. (the “Lender”), subject to satisfactory documentation and the fulfilment of all conditions precedent, for a senior secured first lien credit facility of up to $41.7 million (the “Facility”). The Facility will replace the proposed mortgage loan as well as the sale and leaseback of its Ancaster Energy Centre, which are no longer being pursued by the Company at this time.

The Facility consists of a committed $26.7 million senior secured term loan (the “Loan”) with an 18-month term and 12 monthly interest only payments followed by 6 monthly payments of principal and interest, with the principal component based on a 15-year amortization, and an additional uncommitted $15.0 million senior secured term loan (the “Accordion Loan”), with terms to be agreed between the Lender and the Company. The interest rate on the Loan will be 13% per annum and the Loan will be secured by a first lien against all assets of the Company and its material subsidiaries. The Company will issue 7,000,000 common share purchase warrants of the Company (“Warrants”) to the Lender, subject to standard adjustment provisions, on the date of closing of the Loan. Each Warrant shall be exercisable to acquire one common share of the Company for a period of 36 months from closing of the transaction at an exercise price of C$1.00 per Warrant.

Upon closing of the Loan, TGOD will receive $26.7 million . A further $15 million may be made available by the Lender under the Accordion Loan upon the Lender’s credit approval and the achievement of certain operating and financial milestones, to be agreed, which the Company expects to obtain and achieve not earlier than the end of the third quarter of 2020.

The Loan’s gross proceeds of $26.7 million to be received on closing (which includes the financed portion of a fee in the amount of $1.7 million ) compares to the combined total of $26 million that was expected in the first tranches of the mortgage loan and the sale and leaseback previously considered by the Company. In addition, the interest only payments under the Loan in the first-year amount to only $3.5 million in cash outflow, compared to a total of $7.1 million in cash outflow for interest and lease payments that would have been due under the mortgage loan and the sale and leaseback agreement. As such, this new lending arrangement represents a net positive for committed cash flow. The Company does not consider the difference in amounts from the Accordion Loan expected later in 2020 to impact the viability of the production ramp-up to operating cash flow by the second quarter of 2020.

The Loan is subject to completion of customary closing conditions, including satisfactory documentation, with expected completion of conditions precedent and closing on December 20, 2019 and in any event prior to December 31, 2019 . The underwriter of the Company’s previously announced bought deal public offering of units has consented to the entering into of the Loan.

Continue reading
 0 Comments
0 Comments

2 Marijuana Stocks To Watch Before The New Year

California and Canada represent two of the largest cannabis markets in the world. In the past year or so, the shifting legislation has resulted in one of the fastest-growing industries. Canada is undoubtedly leading the charge on the legislative front as they have recreationally legalized marijuana on a nationwide scale. This does not mean that they are out of the water, as they still have a lot more to go in order to see their market become greatly successful.

California, on the other hand, has seen its industry become recreational as well in the past few years. The state is currently contending with the largest pot market in the nation which makes them an example for the industry. California however, has seen quite a bit of issues in terms of high tax rates and a burgeoning black market. These issues do seem like they are declining as the state takes into consideration the issues that it is facing. For now, these two companies could be marijuana stocks to watch.

Marijuana Stocks To Watch #1 Integrated Cannabis Company Inc.

Integrated Cannabis Company Inc. (ICNAF Stock Report) (ICAN) is one of the leading licensed manufacturers and cultivators of cannabis products. For some time now, it has been working in the Californian and the Nevada market. After licensing Ganja Gold back a few years ago, the company was able to move into the Oakland market, where they have seen great success.
With operations starting small, the company was able to turn its Oakland division into a 32,000 square foot facility that is fully licensed for cultivation. Additionally, the company also operates a state of the art, custom pre-roll manufacturing machine.

Recently, the company announced that sales are forecast to grow from around $9 million this year, up to $25 million by 2021. This estimate does not seem too far off considering the amount of growth that has been witnessed up to this point. The company is also doing a solid job contending with the current high levels of volatility amongst pot stocks. For this reason, it remains one of the marijuana stocks to watch.

Marijuana Stocks To Watch #2 Aphria Inc.

Aphria Inc. (APHA Stock Report) has been beaten-down this year. The company has seen its shares drop by as much as 75%. Despite the incredible levels of fluctuation in the current pot stock market, the company has managed to continuously grow over the past few quarters. The stock has bounced back 20% off its 52-week low.

Continue reading
 0 Comments
0 Comments

Will These Marijuana Stocks Be Ready For 2020?

With many marijuana stocks looking to rebound from the current downtrend, only a few have managed to bounce back. Some of these marijuana stocks to watch may not be the largest, but they present an interesting opportunity for the sector. One of the main reasons for the downtrend comes in the form of high volatility. This is mostly due to the effect of speculative trading. Speculation may be a strategy for some, but it does present some challenges in the face of expanding into a broader market.

Trading based on events and news seems to be how the market works. Yet it does undermine the value of a given pot stock. As well, it is not the best plan for growth heading into the future of the cannabis industry. Regardless, it seems like a few select pot stocks have been able to beat out this adversity.

Global Pot Stocks To Watch

SOL Global Investments Corp. (SOL ) (SOLCF Stock Report) is an internationally focused pot stock working on cannabis-related businesses in the U.S. and Europe. The company has stated that its move into Europe comes at a time when the industry for hemp and CBDs are growing at a fast pace. Through its strategic investments, the company has been able to participate in many different aspects of the cannabis industry.

This includes cultivation, distribution, and retail. Additionally, SOL Global is involved with the University of Miami on its research and development program. This program should be able to produce some new products that will soon be for sale in the cannabis market.

[Read More] 

Continue reading
 0 Comments
0 Comments

2 Marijuana Stocks To Watch Before Friday 13th

Though some might believe marijuana stocks haven’t reached a bottom yet. There are others who believe that the cannabis industry is set for big growth in 2020. With so much news being thrown around the industry, how can we decide on which marijuana stocks to buy? This question, of course, has a multi-part answer that involves a thorough amount of research.

When investors go through their due diligence process it helps eliminate risk to determine which pot stock to watch. And that is what it really comes down to. Each and every investor should spend time figuring out what investment strategy is right for them.

This means when an investor is using the right strategy, they can figure out which companies fit that exact goal they are trying to meet. With pot stocks, finding that strategy can be difficult. With this, however, we are seeing a trend amongst some key pot stocks that makes them look like interesting choices for the near future.

Marijuana Stock To Watch: Beyond Retail

AgraFlora Organics (AGRA) (AGFAF Stock Report) is an international focused cannabis company. Recently AgraFlora announced that the Company’s United Kingdom subsidiary, Farmako Limited has finished its UK Home Office inspection for the purpose of obtaining a Controlled Drug License. Farmako Limited has previously been granted certification for its compliance with Good Distribution Practice.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 12, 2019

DNA Genetics Announces Entry into CBD Market Through Licensing Deal with 1933 Industries Inc. (TGIF) (TGIFF)

OG DNA Genetics (“DNA” or the “Company”), a globally recognized leading cannabis brand, today announced a second licensing agreement (the “Agreement”) with 1933 Industries (“1933”), a leading cultivator and producer of cannabis flower and concentrates and manufacturer of hemp-derived CBD wellness products.

Click To Read Full Press Release

North American Marijuana Stocks To Watch This Month

When it comes to marijuana stocks value is something that is talked about. With many pot stocks to watch, it can be difficult to choose the best companies. With lots of information at hand, it becomes easier to make a decision on which marijuana stocks to buy. Within the cannabis industry, there are different sub-sectors to consider. These could be companies involved in financing as well as those who provide ancillary services to the market.

See For Yourself

AgraFlora Organics International Inc. (AGRA) (AGFAF) Completes UK Home Office Controlled Drug Handling License Inspection

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce that the Company’s United Kingdom (the “UK”) subsidiary, Farmako Limited has completed its UK Home Office inspection for the purpose of obtaining a Controlled Drug License.

Click To Read More

Disclaimer:

Continue reading
 0 Comments
0 Comments

DNA Genetics Announces Entry into CBD Market Through Licensing Deal with 1933 Industries Inc. (TGIF) (TGIFF)

DNA Genetics Announces Entry into CBD Market Through Licensing Deal with 1933 Industries Inc.

 

OG DNA Genetics (“DNA” or the “Company”), a globally recognized leading cannabis brand, today announced a second licensing agreement (the “Agreement”) with 1933 Industries (“1933”), a leading cultivator and producer of cannabis flower and concentrates and manufacturer of hemp-derived CBD wellness products.

This Agreement will grant 1933 license to the DNA brand for the production and sale of hemp-derived CBD products – signaling DNA’s first entry into the CBD market. The Agreement allows DNA to leverage 1933’s vast distribution network of over 800 retail outlets throughout the United States . In 2018, the Farm Bill was passed through legislation federally legalizing the cultivation of hemp and permitting the sale of hemp-derived CBD products. This gives DNA the ability to expand their reach into the rapidly developing CBD market and provide the highest-quality products to all 50 states and globally.

“We are excited to expand our partnership with 1933, one of leaders in the CBD wellness space,” said Don Morris , Co-Founder of DNA Genetics. “It feels good to build on an already strong relationship with a like-minded company committed to putting out the best quality products.”

“DNA has always set a standard in breeding and cultivation, resulting in the best quality products in the market,” said Chris Rebentisch , CEO of 1933. “It’s fitting that we would work together to help bring the legacy brand into the CBD wellness space. We have an amazing lineup of products and are excited to leverage DNA’s global reach through this agreement.”

Continue reading
 0 Comments
0 Comments

United Cannabis Corporation (CNAB) Receives Notice of Allowance for New Patent

United Cannabis Corporation Receives Notice of Allowance for New Patent Covering Methods of Preparing and Using Cannabinoid Formulations

United Cannabis Corporation (OTCBB: CNAB) (the “Company” or “United Cannabis”) announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) for its application for a new patent that claims methods of using and preparing cannabinoid formulations.  The allowed application will mature into an issued patent once the issue fee is paid to the USPTO.

The allowed application is a divisional of the application that was previously allowed by the USPTO and which matured into the Company’s US Patent No. 9,730,911 (the “‘911 Patent”).  The ‘911 Patent was issued on August 15, 2017.

Jesús Vázquez, Vice President and General Counsel of the Company and who was recently named as one of the “50 Most Influential People in IP 2019: Industry Leaders” by the publication “Managing Intellectual Property,” commented: “The new patent will compliment and will have the same priority date as our ‘911 Patent.  It will be a valuable addition to the Company’s patent portfolio.”

Vázquez added: “The USPTO concluded that the claims in the new patent “are neither anticipated nor rendered obvious over the record.”  This is significant because the materials in the “record” that were reviewed by the USPTO include materials that our adversary in pending litigation has argued invalidate our ‘911 Patent.  If those materials do not invalidate the claims in the new patent, they do not invalidate the claims in the ‘911 Patent.”

Earnie Blackmon, Chief Executive Officer of United Cannabis, commented: “This  development further confirms and protects our innovative approach to the advancement and use of cannabinoids for medical applications. As the broader medical and regulatory communities begin to recognize the opportunities within the sector it is increasingly important that we protect the innovations we have developed and the investment we have made along the way.”

About United Cannabis Corporation

Continue reading
 0 Comments
0 Comments

AgraFlora Organics International Inc. (AGRA) (AGFAF) Completes UK Home Office Controlled Drug Handling License Inspection

AgraFlora Organics Completes UK Home Office Controlled Drug Handling License Inspection

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce that the Company’s United Kingdom (the “UK”) subsidiary, Farmako Limited has completed its UK Home Office inspection for the purpose of obtaining a Controlled Drug License.

Farmako Limited had already been granted certification for its compliance with Good Distribution Practice (“GDP”) and received an authorization for the wholesale distribution (“WDA”) of medicinal products, including medical cannabis, in summer 2019 after completing a successful inspection by the UK’s Medicines and Healthcare Products Regulatory Agency (the “MRHA”) earlier this year.

The UK medicinal cannabis market value is forecast to reach almost US$1.3 billion by 2024. Prohibition Partners’ has also estimated that up to 1 per-cent of the UK population could qualify as medical cannabis patients by 2028.1

Upon receipt of a Controlled Drug License from the UK Home Office, after last week’s inspection, Farmako Limited will be fully licensed to pursue pharmaceutical/medical cannabis trading within the UK operating theatre. Initially, Farmako Limited will pursue the import of Bedrocan products from the Netherlands to the UK for end patient distribution.

Additionally, Farmako Limited reports it is in advanced contract discussions with an external UK domiciled pharmaceutical logistics firm which will function as the Company’s secured UK warehousing and shipping hub.

Recent UK legislation allows for the prescription of cannabis from medical specialists through a regular pharmacy model. Access to this high-profile market, when coupled with broad National Health Service (“NHS”) insurance coverage for medical cannabis to ensure better patient outcomes, is a key strategic element of AgraFlora’s global platform.

Continue reading
 0 Comments
0 Comments

2 Marijuana Stocks To Watch After Earnings

In the past year or so marijuana stocks have faced more hurdles. Many of these obstacles are legislative issues. However, in the midst of all this, public perception has also changed. Currently, in the cannabis industry, we are seeing a high level of volatility sweeping through the market. It can be difficult to use only one strategy when looking for marijuana stocks to buy.

This, however, becomes much easier with a proper amount of research. Most investors usually use fundamental and technical due diligence as a strategy. This allows investors to foresee any surprises when selecting a company. Though everyone has access to the information that exists, using this information to one’s advantage, is what separates a profitable investor or a poor one.

Marijuana Stocks To Watch: CBD and Hemp Companies

SOL Global Investments Corp. (SOL Stock Report) (SOLCF Stock Report) is an international investment company. SOL Global has stated that it has a heavy interest in cannabis-related businesses in the U.S. Additionally, the goal for the business is to move deeper into the emerging European hemp and CBD market. The company has also mentioned that through its investments and partnerships, it is able to participate in the various aspects of the cannabis industry. This includes cultivation, distribution, and retail. The company also has a research and development program with the University of Miami.

Recently, SOL Global announced that it has completed a $50 million financing transaction by way of debenture units. With the new proceeds that the company has accumulated, it should be able to push forward with new working capital for new projects. This could help build out its hemp and CBD strategy. Only time will tell.

Continue reading
 0 Comments
0 Comments

North American Marijuana Stocks To Watch This Month

When it comes to marijuana stocks value is something that is talked about. With many pot stocks to watch, it can be difficult to choose the best companies. With lots of information at hand, it becomes easier to make a decision on which marijuana stocks to buy. Within the cannabis industry, there are different sub-sectors to consider. These could be companies involved in financing as well as those who provide ancillary services to the market. This is meant to illustrate that there are a lot of options when it comes to investing in marijuana stocks.

The cannabis industry has had its setbacks this year. However, the marijuana business conference began in Las Vegas on Monday which could turn more attention to the industry heading into 2020.

“We are undergoing a recalibration in a very painful way” said Scott Greiper, president of Viridian Capital Advisors. “Markets are really depressed right now and we are looking for ways to come out of it.”

North American Marijuana Stocks To Watch #1

4Front Ventures (FFNTF Stock Report) (FFNT) is a promising company working on a long term strategy. The company has stated that their success will be based on tested operating capabilities and committed leadership board. Earlier this month the company signed a letter of intent to divest 100% of its economic interests associated with three dispensary licenses in Arkansas. The transaction is set to close later this month.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks To Watch As Retail Evolves 

For those who fervently watch marijuana stocks, they know that the past year has had its fair share of ups and downs. With a new year on the horizon, can we expect pot stocks to make a swift comeback? It goes without saying that the cannabis industry is notoriously difficult to predict. With so many ups and downs, searching for the best marijuana stocks to buy with consistent profitability can be a task.

Pot stocks are heavily swayed by speculation. This means that any updated marijuana stock news could impact the industry. This includes things like legislation. For example, recent excitement surrounding the MORE Act has triggered additional interest in the cannabis industry. The high amount of volatility stems from the fact that this is still a young sector. Only in the past few years or so, have they come into the mainstream. We’re approaching a new year, and hopefully, one that can surprise us all for the better.

Marijuana Stocks To Watch: Edibles & Extracts In Focus

AgraFlora Organics (AGRA) (AGFAF Stock Report) is a growth-oriented company targeting international expansion. The company owns and operates an indoor cultivation facility based out of London, ON. Additionally, it is a joint venture partner with Propagation Services Canada and its large scale of 2.2 million square foot facility.

The company recently stated that it is near completion on its 51,000 square foot edibles manufacturing facility in Winnipeg, MA. With this, AgraFlora could be able to produce large quantities of marijuana-infused edibles. The company does this by actively pursuing all of the opportunities it can in the industry.

Continue reading
 0 Comments
0 Comments

Green Thumb Industries Inc. (GTII) (GTBIF )to Open Rise West Palm Beach Its Sixth Retail Location in Florida

Green Thumb Industries (GTI) to Open Rise West Palm Beach, Its Sixth Retail Location in Florida and 35th in the Nation, on December 11

Green Thumb Industries Inc. (GTI) (CSE:GTII) (GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise and Essence retail stores, today announced it will open Rise West Palm Beach, its sixth retail location in Florida and 35th in the nation, on December 11.

“We are thrilled to open our sixth Rise location in Florida and 16th store this year as we continue our expansion throughout the state and country,” said GTI Founder and Chief Executive Officer Ben Kovler. “We remain focused on scaling the business in Florida and across our 12 markets.”

Rise currently has locations in Bonita Springs, Deerfield Beach, Hallandale Beach, Oviedo and Pinellas Park. GTI entered the Florida market in 2019 and operates a manufacturing facility in Homestead where it cultivates and produces GTI’s branded cannabis products including its flagship brand Rythm and The Feel Collection. Rise also offers delivery to registered cardholders in Florida via orders placed at risecannabis.com or calling the store directly.

The number of registered patients in Florida has grown rapidly over the past year, increasing from about 202,000 in December 2018 to more than 413,000 in December 2019. Those interested in the state’s medical marijuana program can visit http://knowthefactsmmj.com.

Rise West Palm Beach is located at 430 Clematis Street in West Palm Beach. Hours are Tuesday through Friday 10 a.m. to 7 p.m. and Saturday 10 a.m. to 6 p.m.

About Green Thumb Industries:

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 11, 2019

Best Marijuana Stocks To Watch Right Now? 1 Up Over 90% This Quarter

Within the many sub-sectors of the cannabis industry, there’ve been a few that show continuous potential. Most investors tend to look at the largest marijuana stocks at first but this method is inherently flawed. This doesn’t mean that one should sway completely away from the larger-cap marijuana stocks, but rather give an opportunity to the small and mid-cap companies as well.

Click Here To Read More

Are These Marijuana Stocks Set For New Highs?

Market volatility is something that is all but synonymous with marijuana stocks. This is due to a variety of factors, but most importantly, the infancy of the cannabis industry. Pot stocks as a whole have only been around for a few years at this point. At least, this is the time period in which we have seen tremendous growth. Volatility is something that can be a big positive for some investors, but not for all.

See For Yourself

Tilray, Inc. (TLRY) Receives Additional GMP Certification at EU Campus

Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. (“Tilray Portugal”) has received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. The GMP certification was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products. This is the second GMP certification for Tilray Portugal, which allows the facility to manufacture and export GMP-certified finished medical cannabis products, including dried flower and oils, from Portugal to international markets with legal medical cannabis regulations.

Click To Read Full Press Release

The post Marijuana Stocks Newsletter – December 11, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

Tilray, Inc. (TLRY) Receives Additional GMP Certification at EU Campus

Tilray® Receives Additional GMP Certification at EU Campus Allowing for International Export of Finished Medical Cannabis Products

Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. (“Tilray Portugal”) has received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. The GMP certification was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products. This is the second GMP certification for Tilray Portugal, which allows the facility to manufacture and export GMP-certified finished medical cannabis products, including dried flower and oils, from Portugal to international markets with legal medical cannabis regulations.

“We are pleased with the continued momentum of our growth strategy across Europe with this additional GMP certification for Tilray’s EU campus in Portugal,” says Brendan Kennedy, Tilray CEO. “This will enable us to export a greater range of medical products to international patients, partners and markets. Our international strategy is an important component in driving profitability and long-term shareholder value.”

Tilray’s EU campus in Portugal is a multi-faceted production facility that includes outdoor and greenhouse cultivation sites; research and quality control labs; and processing, packaging and distribution sites for medical cannabis. Tilray’s EU campus also serves as a hub supporting Tilray’s clinical research and product development efforts across Europe. Multiple harvests are expected at this site in the coming months.

In May 2019, Tilray Portugal received its manufacturing license and initial GMP-certification, allowing the company to manufacture and export wholesale dried cannabis as active substances used as starting materials. In September 2019, Tilray Portugal completed its first export to Germany which was the largest inner European bulk shipment of medical cannabis to date. The additional GMP-certification announced today allows Tilray to supply international markets with pharmaceutical-grade dried flower and oils as finished medical cannabis products.

“We now have two GMP-certified facilities to service our global expansion strategy,” says Sascha Mielcarek, Tilray’s Managing Director in Europe. “We’re pleased to have the ability to export our leading medical cannabis flower and oil products to international markets. We will continue to expand our reach to provide patients access to Tilray’s pharmaceutical-grade medical cannabis products, proudly produced in Europe.”

Continue reading
 0 Comments
0 Comments

 Choom™ (CHOO) CHOOF) Expands Retail Footprint, Opening Two New Cannabis Stores in Alberta

Choom Expands Retail Footprint, Opening Two New Cannabis Stores in Alberta

 Choom (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada , is pleased to announce the opening of two additional Alberta provincially approved cannabis retail licensees in Lethbridge and Camrose, AB .

“These two new stores demonstrate our commitment to the Alberta market, by bringing our unique brand to these communities while creating local employment opportunities. We are committed to providing safe access to cannabis through our Choom stores, and this expansion supports our vision of sharing our unique retail experience across Canada .” said Corey Gillon , CEO of Choom.

406 13 St N, Lethbridge, AB – Friday, December 13, 20194706 73rd Street, Camrose, AB – Open

Operating hours are located on Choom’s website at https://choom.ca/retail#Alberta.

For more information, visit choom.ca.

Say hello to Choom
Choom is an emerging adult use cannabis company whose mission is to establish one of the largest retail networks in Canada . The Choom brand is inspired by Hawaii’s “Choom Gang”—a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, “Choom”. Evoking the spirit of the original Choom Gang , our brand caters to the Canadian adult use market with the ethos of ‘cultivating good times’. Choom is focused on delivering an elevated customer experience through our curated retail environments, offering a diversity of brands for Canadians across a national retail network.

Continue reading
 0 Comments
0 Comments

Are These Marijuana Stocks Set For New Highs?

Market volatility is something that is all but synonymous with marijuana stocks. This is due to a variety of factors, but most importantly, the infancy of the cannabis industry. Pot stocks as a whole have only been around for a few years at this point. At least, this is the time period in which we have seen tremendous growth. Volatility is something that can be a big positive for some investors, but not for all.

With high levels of fluctuations, the opportunity to see large returns in a short period of time is there. Additionally, this also means that there is potential for big losses as well. Much of this comes down to the individual investing style and whether or not volatility is a part of that. With the future looking bright for pot stocks, it seems as though some companies may have a more interesting future than others.

Marijuana Stocks Focusing On Brand Building

1933 Industries Inc. (TGIFF) (TGIF Stock Report) is one of the leading vertically integrated, brand-focused cannabis stocks. The company works out of the U.S. market as well as in Canada. 1933 Industries works with its two wholly-owned subsidiary companies, that it uses to produce leading cannabis brands. With these brands, the company is able to participate in many different aspects of the pot stock market.

This includes cannabis cultivation, extraction, processing and the manufacturing of assets. Because the company has such a broad scope, it has been able to move into the top tiers of the pot stock market. Moving forward, the company remains a key industry leader to watch.

Continue reading
 0 Comments
0 Comments

Best Marijuana Stocks To Watch Right Now? 1 Up Over 90% This Quarter

Within the many sub-sectors of the cannabis industry, there’ve been a few that show continuous potential. Most investors tend to look at the largest marijuana stocks at first but this method is inherently flawed. For starters, the biggest companies have a much larger bureaucracy to answer to. This results in a much slower network of embracing new ideas and change.

This doesn’t mean that one should sway completely away from the larger-cap marijuana stocks, but rather give an opportunity to the small and mid-cap companies as well. These up and coming businesses are working to build out unique models in the market. Additionally, some of the newest companies could soon be the industry leaders as the pot stock market shifts very quickly.

Marijuana Stocks To Watch: Vertical Integration As A Key To Scaling Production

4Front Ventures (FFNTF) (FFNT Stock Report) has focused on vertical integration in order to scale its business. The company has a wholly-owned subsidiary, Pure Ratios, which has been making some larger strides in the industry. Pure Ratios is based out of San Diego, where they participate in the health and wellness side of the market. The company has been working to produce a large number of products to compete with the growing industry. They do this through holistic techniques and healing methods.

Recently, the subsidiary announced that it has opened a new Cannabis Medicine Clinic in Desert Hot Springs, CA. The clinic is the first of its kind and only one at the current moment in time. With this, they will be able to further embark on their mission to give patients the best holistic offerings that they can find.

Continue reading
 0 Comments
0 Comments

1933 Industries (TGIF) (TGIFF) Partners with Premium Cannabis-Infused Food Brand Pantry Food Co for the Production of Edibles in Nevada

Pantry’s chef-created gourmet edibles will be available in the Nevada marketplace in 2020

VANCOUVER , Dec. 10, 2019 /CNW/ – 1933 Industries Inc. (the “Company” or “1933 Industries”) (TGIF.CN) (TGIFF), a vertically-integrated cannabis consumer packaged goods company, is pleased to announce the execution of a two-year licensing agreement (the ‘Agreement’) between the Company’s subsidiary, Alternative Medicine Association LC (“AMA”) and Los Angeles based, The Pantry Company Inc. (“Pantry”), for the production of edible products in Nevada , adding a new vertical to the Company’s portfolio of leading cannabis brands.

Pantry is a premium cannabis-infused food brand created with an emphasis on all-natural ingredients, without preservatives and artificial flavours. Pantry has partnered with award-winning chefs to create a unique line of products for health-conscious and discerning palates, and is currently available for sale across California .

The Company will commence the buildout of a GMP-approved commercial kitchen, to be located in the Company’s extraction facility in Las Vegas, Nevada . The Company expects to begin production of Pantry products mid-2020.

The Licensed Products will initially include the following:

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter For Tuesday December 10, 2019

AgraFlora Organics (AGRA) (AGFAF) Awarded Health Canada Research License at GMP-Certified Toronto, Ontario Bottling Facility and Increases Convertible Debenture Offering

VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce the Company’s subsidiary, Potluck Potions and Edibles Inc., has been awarded a cannabis research licence (the “Research License”) from Health Canada under the Cannabis Regulations Act.

Click For Full Press Release

Marijuana Stocks To Watch Before The End Of The Year

This year hasn’t been kind to marijuana stocks, in general. Have there been some glimmers of hope? Yes. But, for the most part, 2019 marked a tough year all the same. Issues with a slow roll-out of Canada’s recreational industry didn’t help either. This year was the year that extracts finally became legal, which wasn’t included in the country’s first round of cannabis legalization. There could be light at the end of the tunnel however.

See For Yourself 

Pot Stocks To Watch Before 2020: Aphria Inc. (APHA)

Aphria Inc (APHA Stock Report) has been a struggling marijuana stock in recent times to earn strong returns for investors. In the last two years, its stock has dipped over 25%. Although there have been some bright moments they have, nonetheless, been short-lived. But could recent developments pose a stronger year next year for Aphria?

Click To Read More

Dislcaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Agraflora Organics International Inc. (CSE: AGRA) (OTC: AGFAF), Midam is being paid $25,000 per month by Agraflora Organics International Inc. (CSE: AGRA) (OTC: AGFAF) for 6 months during a period of coverage from May 6, 2019 to November 6, 2019. We may buy or sell additional shares of (CSE: AGRA) (OTC: AGFAF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Agraflora Organics International Inc. (CSE: AGRA) (OTC: AGFAF). View Full Disclaimer Here.

Continue reading
 0 Comments
0 Comments

Innovative Industrial Properties (IIPR) Declares Fourth Quarter 2019 Dividends

Common Stock Dividend Increased 28% from Prior Quarter and 186% from Q4 2018

Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a fourth quarter 2019 dividend of $1.00 per share of common stock, representing an approximately 28% increase over IIP’s third quarter 2019 dividend of $0.78 per share of common stock, and an approximately 186% increase over IIP’s fourth quarter 2018 dividend of $0.35 per share of common stock. The dividend is equivalent to an annualized dividend of $4.00 per common share, and is the sixth dividend increase since IIP completed its initial public offering in December 2016.

Additionally, IIP announced today that its board of directors has declared a regular quarterly dividend of $0.5625 per share of IIP’s 9.00% Series A Cumulative Redeemable Preferred Stock.

The dividends are payable on January 15, 2020 to stockholders of record at the close of business on December 31, 2019.

About Innovative Industrial Properties

Continue reading
 0 Comments
0 Comments

AgraFlora Organics (AGRA) (AGFAF) Awarded Health Canada Research License at GMP-Certified Toronto, Ontario Bottling Facility and Increases Convertible Debenture Offering

VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce the Company’s subsidiary, Potluck Potions and Edibles Inc., has been awarded a cannabis research licence (the “Research License”) from Health Canada under the Cannabis Regulations Act.

The Research Licence equips AgraFlora with the ability to develop cannabis infused beverage formulations, as well as complete human sensory testing for taste, appearance, aroma and texture at its GMP bottling facility located in Toronto, Ontario (the “Toronto Bottling Facility”). The Research Licence also allows AgraFlora to possess and store dry cannabis, cannabis oils/concentrates and cannabis edibles on site at the Toronto Bottling Facility.

In anticipation of the Research Licence, AgraFlora began comprehensive retrofit initiatives at the Toronto Bottling Facility including the completion of a cannabis research laboratory (the “Research Laboratory”) within its current GMP-certified premises. The Research Laboratory consists of state-of-the-art equipment for weighing, handling and processing microdosages of CBD and THC compounds, including magnetic mixers, homogenizers and high-pressure liquid chromatograph (“HPLC”).

The Company plans to immediately commence cannabinoid-related research and development activities, including:

Establishment of extraction protocols to isolate specific desirable compounds, including CBD, THC and THCV;
Cannabinoid extract infusion analysis relating to formulation and pilot batching;
Identification of process and physiochemical product attributes paired with analytically guided optimization;
Development of optimized blend formulations for water solubility and shelf stability ratios/forms;
High-pressure homogenization to produce superfine emulsions from cannabis oil; and,
Centrifugal partition chromatography to develop compounds in a powdered format.
AgraFlora’s Toronto Bottling Facility boasts extensive manufacturing experience for leading beverage brands, such as Heineken and SABMiller, as well as the Coca-Cola Company. Strategically situated in the Greater Toronto Area (the “GTA”), the Toronto Bottling Facility affords the Company unbridled access to the largest addressable Canadian marketplace. The GTA is buoyed by established infrastructure, offering the flexibility to accommodate shipments from multiple ports and hubs across North America.

Continue reading
 0 Comments
0 Comments

Pot Stocks To Watch Before 2020: Aphria Inc. (APHA)

Aphria Inc (APHA Stock Report) has been a struggling marijuana stock in recent times to earn strong returns for investors. In the last two years, its stock has dipped over 25%. Although there have been some bright moments they have, nonetheless, been short-lived. But could recent developments pose a stronger year next year for Aphria?

Marijuana Stocks To Watch: Aprhia Inc. (APHA)

To begin, the company is doubling its production capacity. This follows obtaining a growing license for its subsidiary Aphria Diamond. The facility has a production space of 1.2 million sq. ft. It also has the potential of growing 140,000 kg of cannabis annually. With this addition, Aphria’s production increases to 2.4 million sq. ft. with annual production capacity reaching 225,000 kg.

Besides increasing the production capacity another thing that should be noted is the idea that the facility has “industrial-scale automation tech.” This means that it will be able to handle various tasks like transporting plants, waste disposal, trimming and much more. This helps the company bring costs down in price thus helping it add to its margins in the process.

Read More

Continue reading
 0 Comments
0 Comments

Marijuana Stocks To Buy Or Sell: Aurora Cannabis (ACB)

Marijuana stocks have performed poorly this year with top producers falling short of expectations. For instance, Aurora Cannabis (ACB Stock Report) has been bleeding in the last few months. Last month the pot stock dipped 27% plunging into oversold territory following the release of Q1 2020 results.

Marijuana Stocks To Buy Or Sell: Aurora Cannabis (ACB): Disappointing Q1 2020 Results

Ahead of the release of its Q1 2020 earnings results, there was significant anticipation. The company released its earnings results with its YoY gross profit jumping 58% to around $53.7 million. Although this was the highest in the sector its revenue dropped from $94.6 million in the previous quarter to $75.3 million. Also, year-over-year net income dropped significantly from $104.2 million to around $10.4 million.

[Read More] 5 Marijuana Stocks On Robinhood Gaining Popularity In December

The worst news was the company’s announcement that it was planning to stop the construction of the Aurora Nordic 2 facility in Denmark. The company plans to halt construction as a way of saving around $80 million.

This year has been challenging for the company as it has been struggling with cash issues. Therefore, this move shows that Aurora Cannabis is already feeling the pinch. But, at the same time, Aurora isn’t sitting idle. As much as this could hurt in the short-term, capital preservation could play a big role in the future. That may not make it one of the marijuana stocks to buy but it could give reason to add it to a pot stocks watch list.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 9, 2019

Best Pot Stocks To Watch Before Next Quarter?

Pot stocks are in need of some real momentum. The past several months have been less than stellar for the industry as a whole. This was due to a variety of factors including the shifting state of the industry and some general uncertainty about the future. All of this, however, is settling down as the market is moving forward with Cannabis 2.0. Investors continue to search for the best pot stocks to watch.

Continue Reading

5 Marijuana Stocks On Robinhood Gaining Popularity In December

Lately, there’s been a rise in the interest of pot stocks by a younger generation. This generation tends to rely on mobile apps more than they do a desktop. Enter Robinhood, a trading platform built for mobile users that doesn’t charge trading fees. As we close out the year, let’s take a closer look at some of the most popular pot stocks on Robinhood right now.

See For Yourself

Canopy Growth (CGC) names Constellation Brands’ (STZ) CFO David Klein as CEO, effective Jan. 14

SMITHS FALLS, ON, Dec. 9, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce that effective January 14, 2020, David Klein has been appointed as the Company’s Chief Executive Officer.

Click To Read More

The post Marijuana Stocks Newsletter – December 9, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

Canopy Growth (CGC) names Constellation Brands’ (STZ) CFO David Klein as CEO, effective Jan. 14

SMITHS FALLS, ON, Dec. 9, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce that effective January 14, 2020, David Klein has been appointed as the Company’s Chief Executive Officer.

David brings a wealth of expertise to this role, having served in a number of senior leadership capacities over the past 14 years at Constellation Brands. His capabilities include extensive CPG and beverage alcohol industry experience, strong financial orientation, and experience operating in highly regulated markets in the U.S., Canada, Mexico and Europe. David is an experienced strategist with a deep understanding of how to build enduring consumer brands while leveraging operational scale across a dispersed production footprint. He is a strong leader with a proven track record of developing diverse and high performing teams.

In his current role as executive vice president and chief financial officer at Constellation Brands, David oversees all aspects of the company’s finance operations, all mergers and acquisitions, as well as the company’s information technology function. He is widely respected among members of the U.S. investment community, earning recognition as a top CFO by Institutional Investor magazine the past three years. David serves as a member of Constellation Brands’ executive management committee. He has served on the Canopy Growth Board of Directors for over a year and is presently Canopy Growth’s Board Chair. This familiarity with the Company’s current leadership team and strategy will allow David to integrate quickly, a major benefit in the fast-moving cannabis sector.

“Canopy Growth sits at the forefront of one of the most exciting new market opportunities in our lifetime,” said Klein. “Thanks to the efforts of Mark and the entire team at Canopy Growth, no company is better positioned to win in the emerging cannabis market. I look forward to working with the team to build on the foundation that has been laid, to develop brands that strongly resonate with consumers, and to capture the market opportunity before us. Together we will drive sustainable, industry-leading growth that benefits employees, shareholders and the communities in which we operate.”

The appointment of David Klein follows a thorough recruitment process overseen by a special Hiring Committee of the Board using global recruitment company Heidrick & Struggles, which saw a wide variety of exceptional candidates vetted and interviewed. David will step down from all other positions he currently holds, remaining a member of the Canopy Board of Directors. The Company intends to appoint a new Chairperson upon David’s effective date as CEO.

Continue reading
 0 Comments
0 Comments

5 Marijuana Stocks On Robinhood Gaining Popularity In December

Since the advent of trading marijuana stocks, there’ve been plenty of metrics to follow. These metrics are used in order to understand the sheer size and scope of the sector. Lately, however, there’s been a rise in the interest of pot stocks by a younger generation.

This generation tends to rely on mobile apps more than they do a desktop. Enter Robinhood, a trading platform built for mobile users that doesn’t charge trading fees. Some might say it has helped evolve the landscape and opened doors to low or no-fee trading.

We’re still fighting for an end to the PDT Rule (Pattern Day Trade Rule). But cutting fees is a big first step to opening access to all investors. Needless to say, even though there are multiple platforms offering no-fee options, Robinhood was the pioneer. It has also offered interesting metrics that were harder to find on other platforms.

Popular Marijuana Stocks On Robinhood

When it comes to popularity, the app allows users to track certain stocks in groups. One of these is most popular. When it comes to marijuana stocks on Robinhood, it gives a nice glimpse into the money flow in the cannabis industry.

Read More

Continue reading
 0 Comments
0 Comments

Best Pot Stocks To Watch Before Next Quarter?

What Names Will Be Pot Stocks To Watch Before The First Quarter Of 2020?

Pot stocks are in need of some real momentum. The past several months have been less than stellar for the industry as a whole. This was due to a variety of factors including the shifting state of the industry and some general uncertainty about the future.

All of this, however, is settling down as the market is moving forward with Cannabis 2.0. Investors continue to search for the best pot stocks to watch. This has proven to be a more daunting task than most imagine especially right now.

Needless to say, we’re once again at the trailhead of a new opportunity within the sector. Later this month we’ll see new recreational products hit the Canadian market. Just as before, it’s likely that the US uses this for guidance on its own legislative front.

[Read More] What You Should Know About Marijuana Stocks And CBD

With things like the MORE Act still working its way through Washington, sentiment has changed a bit. But even so, eyes are on 2020 to see how the industry can continue evolving. This being said, we’ll take a closer look at a few marijuana stocks to watch before next quarter.

Continue reading
 0 Comments
0 Comments

Are Large Cap Marijuana Stocks A Buy Now?

Can Pot Stocks Start A Recovery This Month?

In the past year or so, we have seen some major downtrends in marijuana stocks. This is due to a variety of factors including bad news hitting the industry. Additionally, there’s been a flurry of legislative challenges too. With all eyes on the new year, many have turned their heads back to Canada to see what’s in store.

One of the largest changes going on right now is that Canada is shifting its legislation for the positive. This means that the industry could completely reshape itself in the near future. Recently, Canada legalized the use of vapes, edibles, and infused products.

[Read More] Marijuana Stocks To Watch Before The End Of The Year

Prior to this, the only legal products allowed were dried flowers, sprays, and oils. This left a lot to be desired for the industry and those who utilize it. What the country realized though, is that they are impeding the growth of the market by not allowing a large number of products into the industry.

Large Cap Marijuana Stocks To Buy (or avoid) Before 2020: Aurora Cannabis

Aurora Cannabis (ACB Stock Report) is widely regarded as one of the largest pot stocks in the market. The company had quite a rough time so far this year. It has also met mounting competition in the Canadian market. Aurora has consistently missed deadlines for a large amount of the facilities that it has worked to build. One of the areas where Aurora has succeeded is the amount of production going on.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter December 6, 2019

Marijuana Stocks To Watch Before The End Of The Year

This year hasn’t been kind to marijuana stocks, in general. Have there been some glimmers of hope? Yes. But, for the most part, 2019 marked a tough year all the same. Issues with a slow roll-out of Canada’s recreational industry didn’t help either. At the same time, we’ve also seen companies readjust and at times, pivot in order to weather this storm. But as the year starts to come to an end, it should have you thinking a few things. First, which pot stocks should be shed and which ones are worth taking a closer look at before 2020?

See For Yourself

Marijuana Stocks: 2 MSO’s To Know Before 2020

When it comes to finding marijuana stocks to watch, multi-state operators (MSO) seem to be a popular topic. With so many to choose from, finding some with the most value can be a daunting task at times. For starters, it’s important to consider the states in which they operate. Some states in the U.S. have a much larger cannabis industry than others.

Continue Reading

Canopy Growth (CGC) Provides Update on 2.0 Product Rollout

SMITHS FALLS, ON, Dec. 6, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) officially revealed its Cannabis 2.0 portfolio of products last week, set to come to market as part of the second wave of Canadian cannabis commercialization. With December 16, 2019, being the first date new product formats can be sold into distribution channels, the Company expects that in most markets new products will not be seen on shelves until early in January 2020.

Read The Full Press Release

The post Marijuana Stocks Newsletter December 6, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

Canopy Growth (CGC) Provides Update on 2.0 Product Rollout

SMITHS FALLS, ON, Dec. 6, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) officially revealed its Cannabis 2.0 portfolio of products last week, set to come to market as part of the second wave of Canadian cannabis commercialization. With December 16, 2019, being the first date new product formats can be sold into distribution channels, the Company expects that in most markets new products will not be seen on shelves until early in January 2020. Leveraging learnings from Cannabis 1.0, the Company will stagger its launch of various products and formats to ensure a smooth roll-out. As such, availability will vary by province based on their individual ordering and distribution activities. While the Company is providing this update in advance of the launch of Cannabis 2.0 products, for competitive reasons, it will not provide ongoing updates during the actual rollout period.

The first wave of cannabis chocolate products, which will arrive in retail in early January 2020, includes Tokyo Smoke Go, Tokyo Smoke Pause, and Tweed Bakerstreet chocolate bars. Tokyo Smoke Go is a THC-infused, sativa-dominant dark milk chocolate with minimal CBD content. Each five-piece chocolate bar contains 10 mg of THC, or 2 mg of THC in each piece. Tokyo Smoke Pause is a THC-infused, indica-dominant dark milk chocolate, containing 2 mg of THC in each of the five squares. Tweed Bakerstreet is blended with peppermint and milk chocolate and offers 2.5 mg of THC in each of the four chocolate squares. The second wave of chocolate bars will include Tokyo Smoke Ease CBD chocolate, expected to be on shelves in late January, as well as the Company’s new brand of high-quality chocolate, Bean & Bud, expected to be on shelves by the end of February 2020.

The first wave of the Company’s ready-to-drink mixed Distilled CannabisTM beverage products – Tweed Houndstooth & Soda, Houseplant Grapefruit, and Houseplant Lemon – are expected to hit shelves in early January 2020. The Company expects to launch additional beverage offerings under the Tweed, Quatreau, and Deep Space brands in the following weeks of January, with its Distilled CannabisTM spirits expected to follow in early February 2020.

On November 28, 2019, Chief Technology Officer Peter Popplewell unveiled Canopy Growth’s lineup of vape pens and vape cartridges. The new products – consisting of cartridges and associated rechargeable batteries – are anticipated to launch late January 2020. Tweed, Twd., and Van Der Pop branded 510 thread format devices remain the Company’s first launch focus, as the 510 thread format comprises approximately 75% of vape extract sales in established markets like Colorado and California. Further differentiated and feature-rich vape offerings are expected to launch thereafter, including the Company’s single-use, recyclable, Bluetooth-enabled Juju Joints line-up of products. The Company will ensure that all products obtain UL 8139 certification prior to coming to market, which it considers the most thorough safety standard for vaping devices. Additionally, the Company is continually reviewing and testing all inputs to ensure the highest quality and reliability of cannabinoids, terpenes, tamper-resistance and product serialization features. The Company recognizes the recent announcements by the provinces of Newfoundland & Labrador and Quebec delaying the launch of vape products in those provinces; as provincial buyers increase their level of scrutiny on the products they sell, the Company will continue to work to meet the highest standards of safety, product quality and transparency for consumers.

The Company looks forward to introducing Canadian consumers to these exciting new product formats.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks To Watch Before The End Of The Year

Which Pot Stocks Do You Have On Your Watchlist In December?

This year hasn’t been kind to marijuana stocks, in general. Have there been some glimmers of hope? Yes. But, for the most part, 2019 marked a tough year all the same. Issues with a slow roll-out of Canada’s recreational industry didn’t help either. This year was the year that extracts finally became legal, which wasn’t included in the country’s first round of cannabis legalization.

At the same time, we’ve also seen companies readjust and at times, pivot in order to weather this storm. But as the year starts to come to an end, it should have you thinking a few things. First, which pot stocks should be shed and which ones are worth taking a closer look at before 2020?

Marijuana Stocks To Watch: An International Investment Focus

SOL Global Investments Corp. (SOL Stock Report) (SOLCF) is one of the leading international investment companies. It has operations in both the U.S. and the emerging European cannabis and hemp marketplaces. The company has stated that through its strategic partnerships and investments, Sol is able to partake in various aspects of the cannabis market.

This includes cultivation, distribution, and retail. Additionally, the company has been working with the prestigious University of Miami. The collaboration has focused on developing new products for sale on the open market. With a unique approach to the industry, Sol continues to be a pot stock to watch.

[Read More] Marijuana Stocks: Building A Pot Powerhouse

Continue reading
 0 Comments
0 Comments

Marijuana Stocks: 2 MSO’s To Know Before 2020

When it comes to finding marijuana stocks to watch, multi-state operators (MSO) seem to be a popular topic. With so many to choose from, finding some with the most value can be a daunting task at times. For starters, it’s important to consider the states in which they operate. Some states in the U.S. have a much larger cannabis industry than others.

This means that the future for a given company could be brighter depending on the actual geolocation. Multi-state operators are considered to be an alternative pot stock as they are not mainly growers of the substance.  This is not to say that they do not have fluctuations because they certainly do, but they differ from that of the largest market cap pot stocks

With multi-state operators, it is also important to consider all of the financial information available about a given company. Owning a large number of dispensaries and physical assets takes a large amount of capital. This means that some companies could not be scheduled for profit for quite a long time. Regardless, the industry is still very young. With that in mind, let’s take a look at a short list of pot stocks to watch before 2020.

Marijuana Stocks To Watch #1: Curaleaf Holdings (CURLF) (CURA)

Curaleaf Holdings (CURLF) (CURA Stock Report) is one of the largest multi-state operators in the industry. The company recently received a buy rating from some top analyst firms.

Continue reading
 0 Comments
0 Comments

First of Its Kind Pure Healing Cannabis Medicine Clinic Opens in Desert Hot Springs

SAN DIEGO, CA / ACCESSWIRE / December 5, 2019 / Pure Ratios Holdings, a subsidiary of 4Front Ventures Corp. (CSE:FFNT.CN)(FFNTF), is pleased to announce the opening of Pure Healing Clinic, a fully integrated holistic medical clinic. The first-of-its-kind clinic, which also has an on-site R&D lab to develop therapeutically driven products, located adjacent to Harborside’s newest dispensary location in Desert Hot Springs, Calif.

Completing its vision of patient-centered holistic CBD offerings, CBD hemp wellness brand, Pure Ratios, opens a one-of-a-kind fully integrated Holistic Medical Cannabis Medicine Clinic and Dispensary containing a research and development lab to further develop their therapeutically driven products. Pure Ratios has always developed its products, including an award-winning 96-hour CBD patch and adaptogenic CBD capsules, with the help of patient feedback, but the new clinic will allow the company to more comprehensively track patient experience and gather feedback that will be used to further refine its products. The clinic will also combine acupuncture, herbal medicine, and modern functional science with the power of cannabis medicine treatments and Pure Ratios’ specially formulated CBD Hemp products.

Pure Healing is located adjacent to Harborside Dispensary’s newest location in Desert Hot Springs. Harborside’s first retail location outside of the Bay Area, the store will also be the first drive-thru dispensary in Southern California. The clinic is a highly unique endeavor because of its focus on personalization for every patient, the development of products through hands-on treatment experience, and the clinical research possibilities that now open up in the field of cannabis medicine.

The Pure Healing Clinic is located at 66205 Paul, Desert Hot Springs CA 92240. Opening day festivities will be on December 7th, 2019 starting with a ribbon cutting ceremony by Desert Springs’ Mayor Scott Matas at 10 am. The Palm Springs Chamber of Commerce and CVCAN will bring city leaders to speak and help the community discover this vital new part of the area, and cannabis medicine expert and founder Chad Conner will be giving lectures in his field of expertise regularly throughout the day.

Developed by Conner and his wife, the founders of Pure Ratios wellness products, practitioners of traditional Chinese Medicine and herbology with over 20 years of experience running integrative clinics, the Pure Healing Cannabis Clinic is the first of its kind. This unique space combines acupuncture, herbal medicine, and modern functional science with the power of cannabis medicine treatments and Pure Ratios’ specially formulated cannabis products.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 5, 2019

AgraFlora Organics (AGRA) (AGFAF) To Acquire 88-Acre Outdoor Cannabis Grow and 27,000 Sq. Ft. Licensed Cannabis Processing Facility

VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce the Company has entered into an interim agreement (the “Agreement”) to acquire 100 per-cent of the issued and outstanding shares of Sanna Health Corp. (“Sanna”).

Read Full Press Release

Marijuana Stocks: Building A Pot Powerhouse

There’s more to marijuana stocks than the market has demonstrated over the last few months. Right now, we’re witnessing a young industry that has realized rampant growth in a very short period of time. This having been said, the cannabis industry has entered a new phase and possibly one designed to scale this time. One of the biggest concerns, when Canada went fully legal, was with regard to meeting demand. How will companies evolve to address this trend?

Click To Read More

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

LONDON and CARLSBAD, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced today that a variety of data, including results from completed Phase 3 trials of EPIDIOLEX® (cannabidiol) oral solution CV, will be presented at the American Epilepsy Society (AES) Annual Meeting, December 6-10, in Baltimore.

Click To Read Full Press Release

Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Agraflora Organics International Inc. (CSE: AGRA) (OTC: AGFAF), Midam is being paid $25,000 per month by Agraflora Organics International Inc. (CSE: AGRA) (OTC: AGFAF) for 6 months during a period of coverage from May 6, 2019 to November 6, 2019. We may buy or sell additional shares of (CSE: AGRA) (OTC: AGFAF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Agraflora Organics International Inc. (CSE: AGRA) (OTC: AGFAF). Click for full disclaimer.

The post Marijuana Stocks Newsletter – December 5, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

Meeting Highlights Include New Phase 3 Data for EPIDIOLEX in Tuberous Sclerosis Complex and Award-Winning Virtual Reality Experience

LONDON and CARLSBAD, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced today that a variety of data, including results from completed Phase 3 trials of EPIDIOLEX® (cannabidiol) oral solution CV, will be presented at the American Epilepsy Society (AES) Annual Meeting, December 6-10, in Baltimore. EPIDIOLEX is approved in the U.S. for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome. It is also approved in Europe, in conjunction with clobazam, for seizures associated with both conditions under the brand name EPIDYOLEX. It is available by prescription for patients two years of age and older.

New data from the Phase 3 study of EPIDIOLEX in patients with tuberous sclerosis complex (TSC) will be presented for the first time at the meeting, along with 3-year safety and efficacy results from an open-label extension study in patients with LGS and Dravet syndrome. GW/Greenwich will host commercial and medical booths as well as a scientific exhibit where AES attendees can learn more about EPIDIOLEX.

The Company will also host an Innovation Pavilion where attendees can discover the stories of those treated with EPIDIOLEX; hear about the journey of the only CBD product approved by the FDA; and attend an interactive expert-panel discussion on managing patients on EPIDIOLEX. Attendees can also immerse themselves in the Company’s CBD growing and manufacturing processes through an award-winning virtual reality experience.

“We are excited to share our latest data for EPIDIOLEX at AES. This is the first time Phase 3 results in TSC will be presented to the epilepsy medical community, along with updated long-term safety and efficacy results in LGS and Dravet syndrome,” said Justin Gover, GW’s Chief Executive Officer. “This has been an exciting first year, with over 15,000 patients treated with EPIDIOLEX, the only FDA-approved cannabidiol (CBD) and the first in a new class of antiepileptic drugs. Our goal is to expand the EPIDIOLEX product label in 2020 to include seizures associated with TSC. Given that the majority of these patients have treatment-resistant epilepsy, we believe there is a need for promising new treatment options.”

Continue reading
 0 Comments
0 Comments

AgraFlora Organics (AGRA) (AGFAF) To Acquire 88-Acre Outdoor Cannabis Grow and 27,000 Sq. Ft. Licensed Cannabis Processing Facility

VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce the Company has entered into an interim agreement (the “Agreement”) to acquire 100 per-cent of the issued and outstanding shares of Sanna Health Corp. (“Sanna”). Sanna is a Canadian cannabis company based in the Greater Toronto Area (the “GTA”), which boasts the following licenses awarded under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”):

 

Standard Cultivation License;Standard Processing License; and,Medical Sales License.

Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora stated: “This is a landmark acquisition for AgraFlora, a transaction that is markedly as transformative as it is accretive- resulting in only an 8 per-cent escrowed, millstone centric dilution to our existing capital structure and a four-pronged strategic advantage for AgraFlora:

 

The integration of Sanna will more than double our forecasted 2020 production capacity;Sanna’s existing on-site infrastructure will allow for complementary, margin-rich extraction capabilities, as well as a mission-critical east-cost high density population presence;Affording us access to a proven and popular, market-leading brand/product portfolio which supplements our already identifiable and successful high-calibre brand suite; and,Equally critically, the acquisition of Sanna will enhance our high-visibility distribution across Canada as the Company gears up for a significant 2020 retail presence across the country, as well as other emerging jurisdictions.”

LICENSED EXTRACTION

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 4, 2019

Will These Marijuana Stocks Exceed Expectations?

With pot stocks, finding the one with the most forward-thinking can be a difficult task. But hey, that’s where we come in. These two pot stocks are working to bring the future of the industry into the present. As they continue to traverse the ever-growing market, it seems as though there are some aspects that they have been able to get right for growth.

See For Yourself

22nd Century Group (XXII) Enters CBD Health and Wellness Market

Williamsville, NY, Dec. 03, 2019 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis plant research, announced today the initial closing of an investment in Panacea Life Sciences, Inc. (Panacea), a rapidly-growing, vertically-integrated, consumer-facing company operating exclusively in the legal, hemp-derived, CBD product space.

Click To Read Full Release

Is This Marijuana Stock Still Leading The Race?

When there is a drop in the market within a sector, it becomes advantageous for investors to look for bargains. The cannabis industry has been in the middle of such a sustained downward spiral for many months and there are some opportunities to be had when looking at marijuana stocks.

Continue Reading

The post Marijuana Stocks Newsletter – December 4, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

22nd Century Group (XXII) Enters CBD Health and Wellness Market

Investment provides platform to commercialize 22nd Century’s unique hemp/cannabis plant lines in development and leverage strengths in consumer-packaged-goods and FDA-regulatory affairs

Williamsville, NY, Dec. 03, 2019 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis plant research, announced today the initial closing of an investment in Panacea Life Sciences, Inc. (Panacea), a rapidly-growing, vertically-integrated, consumer-facing company operating exclusively in the legal, hemp-derived, CBD product space. 22nd Century’s investments in Panacea over the next twelve to eighteen months are expected to total $24 million, in a combination of cash and 22nd Century stock in exchange for Panacea-issued debt and preferred equity. 22nd Century has also received a warrant to purchase preferred stock of Panacea, which upon full exercise will provide 22nd Century with a controlling equity position in Panacea.

“After a disciplined and thorough review of the opportunities available to 22nd Century to maximize shareholder value creation, we are pleased to announce the Company’s first investment in the legal, hemp/cannabis, consumer packaged goods space,” said Cliff Fleet, President and Chief Executive Officer of 22nd Century Group. “This investment is a major milestone in 22nd Century’s on-going execution of our hemp/cannabis strategic growth plan and offers the opportunity for strong projected shareholder returns.

“Our objective is to build a leading, profitable business in the fast-growing, emerging, legal hemp/cannabis space, and Panacea is a rapidly-growing, vertically-integrated, consumer-facing business with a very strong management team. We plan for Panacea to be a platform operating company in the hemp/cannabis space that is able to leverage our leadership in cannabis-plant research, our comprehensive expertise in FDA-regulated spaces, and our leadership team’s deep experience in consumer packaged goods,” Fleet explained.

“We are pleased to enter into this long-term strategic partnership with 22nd Century,” said Leslie Buttorff, Chief Executive Officer of Panacea Life Sciences, Inc. “With a strong team and seed-to-sale operations in place, Panacea is on track to deliver sales growth of over 1,000 percent in 2019, with gross margins over 50%. Our success has been possible because of our focus from day one on producing and marketing the highest-quality, hemp-derived, premium CBD products.

Continue reading
 0 Comments
0 Comments

Will These Marijuana Stocks Exceed Expectations?

The marijuana stock market has definitely seen some better days than those of the past few months. Despite an overwhelming amount of bearish support in the industry, some pot stocks have been able to move forward into the future. These companies are putting forth a large amount of innovation to help bring expectations to reality. With so many different pot stocks to choose from, it can be difficult to deduce which ones have the most value. This, however, becomes much easier with a heightened amount of research into the given company.

With an ample amount of information at hand, making an educated decision can become much easier. With pot stocks, finding the one with the most forward-thinking can be a difficult task. But hey, that’s where we come in. These two pot stocks are working to bring the future of the industry into the present. As they continue to traverse the ever-growing market, it seems as though there are some aspects that they have been able to get right for growth.

A Pot Stock Moving Into Edibles

AgraFlora Organics (AGRA Stock Report) (AGFAF Stock Report) is one of the leading growth-oriented and diversified pot stocks working out of the international industry. The company currently owns and operates an indoor cultivation facility based out of London, ON. Additionally, they are a joint venture partner with Propagation Services Canada for a large scale 2.2 million square foot facility.

[Read More] What You Should Know About Marijuana Stocks And CBD

In the past few months, they have been working to retrofit a 51,000 square foot edibles manufacturing facility based out of Winnipeg, MA. With such a broad scope across the Canadian pot stock market, the company has been able to continue growing amidst larger challenges. Additionally, their track record of boosting shareholder value has helped to bring them even further into the spotlight.

Continue reading
 0 Comments
0 Comments

Is This Marijuana Stock Still Leading The Race?

When there is a drop in the market within a sector, it becomes advantageous for investors to look for bargains. The cannabis industry has been in the middle of such a sustained downward spiral for many months and there are some opportunities to be had when looking at marijuana stocks.

One particular marijuana stock that is being touted by experts as a huge bargain is Aurora Cannabis Inc (ACB Stock Report). Which is one of the largest cannabis producers in the whole industry. Yet due to oversupply issues the slow rollout of retail stores in the province of Ontario. Which has suffered like other companies as well.

Key Developments

The company got a major boost this past week after announcing that regulators are willing to grant more retail licenses in Ontario. This would significantly boost the number of cannabis retailers in the province. It had been the biggest problem for Aurora this year and it is no surprise that the market feels much more optimistic about its prospects now. On the other hand, the legalization of cannabis derivative products in Canada, later on, this year could be another major boost for this notorious marijuana stock, considering the fact that it is one of the two biggest producers in the industry.

Aswell Aurora has made impressive moves into the international market. They have established a presence in both South America as well as in Europe. Analysts believe that the industry could be worth $75 billion in sales. With that boost that should be a major argument in favor of Aurora’s long term prospects. Yet, it should be kept in mind that in order to raise capital, the company might need to dilute its shares.

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter – December 3, 2019

December is a New Month for Marijuana Stocks

The marijuana stock market has definitely seen better days than those of the past few months. At that time, many companies have seen their values drop down quite substantially. This is not to say that some pot stocks have not witnessed growth in that time. Many of the most unknown companies in the industry have been able to escape the high levels of volatility. These mid and small-cap pot stocks have a much easier time putting through innovation due to the lack of a major bureaucracy that comes with size.

See For Yourself

What You Should Know About Marijuana Stocks And CBD

CBD is one of the most widely talked about substances of the present day. With so much going on from legislation to news and more, it seems as though cannabidiol is all investors have on their minds. With a less than stellar 2019 for most marijuana stocks thus far, it seems as though it is worth considering that CBD may be the future.

Continue Reading

In Case You Missed It: SOL Global (SOL) (SOLCF) Reports Second Quarter Results

Invested Amount in Key Assets Including Heavenly Rx And Florida Cannabis Operations…SOL Global Investments Corp. (“SOL Global” or “Company”) (SOL.CN) (SOLCF) (9SB.F) released its financial results as at and for the three and six-month period ended September 30, 2019. All figures are reported in Canadian dollars ($), unless otherwise indicated.

Click To Read Full Release

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and AMWPR INC., Midam is being paid $105,000 for coverage on SOL Global Investments Corp, for a period from August 1, 2019 to November 1, 2019. As of July 25, 2019, we have been paid $50,000. We may buy or sell additional shares of (CSE: SOL) (OTC: SOLCF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about SOL Global Investments Corp. (CSE: SOL) (OTC: SOLCF). Click for full disclaimer.

The post Marijuana Stocks Newsletter – December 3, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

 0 Comments
0 Comments

What You Should Know About Marijuana Stocks And CBD

CBD is one of the most widely talked about substances of the present day. With so much going on from legislation to news and more, it seems as though cannabidiol is all investors have on their minds. With a less than stellar 2019 for most marijuana stocks thus far, it seems as though it is worth considering that CBD may be the future.

There are some definite roadblocks in the way of the CBD market flourishing. This includes a lack of proper knowledge regarding the substance as well as lacking legislation for how it is sold. Last week, the FDA wrote an update regarding the substance that may shift the future of the industry. So what exactly is the deal with CBD in the pot stock market?

What is CBD?

For starters, it’s worth noting some of the basics about CBD. CBD or cannabidiol is one of the main components of the cannabis plant. It can be derived from both cannabis and hemp and is legal around the U.S. after the passing of the Farm Bill last year. Unlike its psychoactive brother, CBD does not get the user high.

[Read More] Can These Marijuana Stocks Continue To Build Momentum?

Continue reading
 0 Comments
0 Comments

Tilray® (TLRY) Expands Global Leadership Team With New Manitoba Harvest President

NANAIMO, British Columbia–(BUSINESS WIRE)–

Former Mattel and General Mills executive, Katy Dickson, joins Tilray’s leadership team as Manitoba Harvest President to continue global growth for hemp foods

Today, Tilray, Inc. (TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced the expansion of its global senior leadership team with the appointment of Katy Dickson as President, Manitoba Harvest. Tilray acquired Manitoba Harvest, the world’s largest hemp food company, in early 2019.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191203005191/en/

Dickson joins Tilray from global toy and entertainment leader Mattel, where she served as Senior Vice President, Global Brand GM and President of American Girl. At American Girl, Dickson led initiatives to further build the premium brand and expand internationally. Prior to Mattel, Dickson worked for global media and information leader NewsCorp, where she served as EVP and Global Chief Marketing Officer for the company’s News America Marketing (NAM) division. Prior to NewsCorp, Dickson spent close to 25 years with General Mills, where she held numerous senior marketing and brand management roles, including Vice President, GM of the Old El Paso and Betty Crocker Dinners businesses.

Continue reading
 0 Comments
0 Comments

December is a New Month for Marijuana Stocks

The marijuana stock market has definitely seen better days than those of the past few months. At that time, many companies have seen their values drop down quite substantially. This is not to say that some pot stocks have not witnessed growth in that time. Many of the most unknown companies in the industry have been able to escape the high levels of volatility. These mid and small-cap pot stocks have a much easier time putting through innovation due to the lack of a major bureaucracy that comes with size.

One of the best ways to discover which companies these are is to ensure that one has done all of the research possible. With that, one can have a much easier time avoiding the surprises of high levels of ups and downs in the industry. With pot stocks, there are no guarantees as with any other market. This means that investors will have to put in overtime in order to see real returns. These pot stocks are working to become the main companies to watch moving forward.

A Brand Focused Pot Stock Worth Watching

1933 Industries Inc. (TGIFF Stock Report) (TGIF) is one of the leading vertically integrated pot stocks with operations based out of the U.S. and Canada. The company works with a series of wholly-owned brands that it uses to operate within many facets of the pot stock market. Through its two subsidiaries, it is able to participate in various aspects of the industry. This includes cannabis cultivation, extraction, processing and the manufacturing of assets. With such a broad scope, 1933 Industries remains one of the most prominent pot stocks to watch moving forward.

The company recently announced that they have introduced their newest product to the market. The product, known as Birdhouse CBD Balm by Canna Hemp X was created in collaboration with Birdhouse Skateboards. With this, the company aims to target the action sports market which has seen a large amount of growth in the past year or so. Additionally, the product will be sale in a wide rang of outlets. This includes dispensaries, wellness stores, skate shops and some specialty retailers. With such a broad market base for this new product, the company looks like they could remain on top moving forward.

Continue reading
 0 Comments
0 Comments

SOL Global (SOL) (SOLCF) Reports Second Quarter Results for the Three and Six-Month Period Ending September 30, 2019

TORONTO–(BUSINESS WIRE)–

Invested Amount in Key Assets Including Heavenly Rx And Florida Cannabis Operations

SOL Global Investments Corp. (“SOL Global” or “Company”) (SOL.CN) (SOLCF) (9SB.F) released its financial results as at and for the three and six-month period ended September 30, 2019. All figures are reported in Canadian dollars ($), unless otherwise indicated.

Despite market-wide volatility, SOL Global held fast to its strategic direction and deepened its investments in the Florida cannabis market via One Plant Florida, formerly 3 Boys Farm, LLC. With the goal of producing the highest quality flower in the State of Florida, SOL Global invested an additional $8 million dollars USD into One Plant Florida to fund strategic initiatives to meet that goal, including the construction of its previously announced expansion of cultivation and processing facilities in Indiantown, the addition of a fleet of delivery vehicles, and the buildout of retail dispensaries in key retail corridors including the opening of the first dispensary in Boynton Beach, Florida on November 6, 2019. During the three-month period ended September 30, 2019, SOL Global and its competitors were affected by industry-wide material market challenges across the cannabis and CBD sectors. The Company plans to continue focusing its efforts and investments on its California and Florida operations to provide value to its shareholders.

Corporate Highlights:

Continue reading
 0 Comments
0 Comments

Marijuana Stocks Newsletter for December 2, 2019

Can These Marijuana Stocks Continue To Build Momentum?

In the past year or so, we have seen that marijuana stocks have started to shift. With so many new updates to the cannabis industry, it can at times be difficult to keep up with where the market is headed. Most investors tend to look at the companies at the top of the pot stock market. But as we’ve come to find, there are so many more marijuana stocks to watch.

Continue Reading

4Front (FFNT) (FFNTF) Reaches Deal to Divest Arkansas Assets

VANCOUVER and PHOENIX, Dec. 2, 2019 /PRNewswire/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), has signed a letter of intent to divest 100% of its economic interests associated with three dispensary licenses in Arkansas for a combination of cash and debt.

Click For Full Release

These Marijuana Stocks Are Looking To Make A Come Back

Within America, the individual statewide markets have been able to fuel their own growth. With these individual areas, the pot stock market can cater to the individual needs of the industry. This means that we have seen quite the amount of expansion over the course of the past few months and that could mean big things for certain companies.

See For Yourself

2 Marijuana Stocks To Watch Before Christmas

What is certain is that pot stocks remain one of the most exciting markets of the present day. With so much shifting quickly, it seems as though some companies are working harder for the future than others. These marijuana stocks are putting innovation first in the fight to be on top. As we continue to push ahead the next few years, the hopes are that these key pot stocks can remain with their eyes set forward.

Click To Read More

Continue reading
 0 Comments
0 Comments